Canopy Growth CGC
NASDAQ CGC
$1.03 0.00 (-0.48%)
At close: Aug 20, 2026 · 12:52 PM UTC

Canopy Growth (CGC) Non-Current Deferred Tax Liability (2017 - 2026)

Canopy Growth (CGC) posted Non-Current Deferred Tax Liability of $6.0 million for Q1 2026, up 569.26% sequentially from $893343.0 in Q2 2023.

Canopy Growth (CGC) Non-Current Deferred Tax Liability (2017 - 2026) Analysis & Trends

Canopy Growth has reported Non-Current Deferred Tax Liability for 8 years, with the latest figure at $6.0 million in Q1 2026.

  • Quarterly Non-Current Deferred Tax Liability changed N/A year-over-year to $6.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.0 million (changed N/A YoY) and the FY2026 annual result came in at $6.0 million, changed N/A from the prior year.
  • Non-Current Deferred Tax Liability climbed to $6.0 million in Q1 2026 per CGC's latest filing, from $893343.0 in the prior quarter.
  • Over five years, Non-Current Deferred Tax Liability peaked at $12.6 million in Q1 2022 and troughed at $264071.6 in Q1 2023.
  • A 3-year average of $6.5 million and a median of $6.6 million in 2022 frame the typical range for Non-Current Deferred Tax Liability.
  • The sharpest annual moves came in 2022 and 2023: Non-Current Deferred Tax Liability declined 25.26% in 2022, then sank 97.91% in 2023.
  • Over 3 years, Non-Current Deferred Tax Liability stood at $6.6 million in 2022, then tumbled by 86.51% to $893343.0 in 2023, then surged by 569.26% to $6.0 million in 2026.
  • According to Business Quant data, Non-Current Deferred Tax Liability over the past three periods registered $6.0 million, $893343.0, and $264071.6 for Q1 2026, Q2 2023, and Q1 2023 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 43.98 Bn 43.02 Bn -
2 Teva Pharmaceutical Industries 43.28 Bn 39.62 Bn 2.15 Bn
3 Zoetis 31.78 Bn 30.11 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.71 Bn 22.91 Bn 5.10 Bn
5 United Therapeutics 22.25 Bn 19.59 Bn 683.80 Mn
6 Viatris 18.72 Bn 17.83 Bn 1.46 Bn
7 Neurocrine Biosciences 15.57 Bn 15.18 Bn 935.80 Mn
8 Elanco Animal Health 11.87 Bn 11.34 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.14 Bn 9.97 Bn -
10 Canopy Growth 437.04 Mn 190.03 Mn 16.08 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 5.72 Mn
Jun 30, 2026 5.72 Mn
Mar 31, 2026 5.98 Mn
Mar 31, 2026 5.98 Mn
Jun 30, 2023 893,342.96
Jun 30, 2023 893,342.96
Mar 31, 2023 264,071.60
Mar 31, 2023 264,071.60
Dec 31, 2022 6.62 Mn
Dec 31, 2022 6.62 Mn
Sep 30, 2022 7.48 Mn
Sep 30, 2022 7.48 Mn
Jun 30, 2022 11.50 Mn
Jun 30, 2022 11.50 Mn
Mar 31, 2022 12.62 Mn
Mar 31, 2022 12.62 Mn
Dec 31, 2021 21.71 Mn
Dec 31, 2021 21.71 Mn
Sep 30, 2021 20.23 Mn
Sep 30, 2021 20.23 Mn